The Gamaleya Institute is ready to file papers to Russian Health Ministry to obtain permission for research of new platforms for COVID vaccines, Institute...
Russia’s Gamaleya National Research Center for Epidemiology and Microbiology is launching trials of its new anti-COVID medicine based on monoclonal antibodies, the center’s chief...